Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis
Christoph Roderburg(Universitätsklinikum Aachen), Tom Luedde(Heinrich Heine University Düsseldorf), Norbert Frey(Heidelberg University), David Vargas Cardenas(RWTH Aachen University), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), David Scholten(RWTH Aachen University), Mark Luedde(Christian-Albrechts-Universität zu Kiel), Christian Trautwein(TUM Klinikum)
Cited by 158
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786